HighTower Advisors’s Medtronic MDT Stock Holding History

HighTower Advisors’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-10	Closed	-$7K	–	3426
2022 Q1	$7K	Buy	+10	New	+$1.06K	﹤0.01%	3240
2021 Q1	–	Sell	-20	Closed	-$11K	–	3182
2020 Q4	$11K	Sell	20 -980	-98%	-$108K	﹤0.01%	2512
2020 Q3	$7K	Buy	+1,000	New	+$100K	﹤0.01%	2443
2019 Q3	–	Sell	-2,000	Closed	-$4K	–	2489
2019 Q2	$4K	Buy	+2,000	New	+$183K	﹤0.01%	2329

Other funds holding MDT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HighTower Advisors's MDT Position: Q1 2026 in Review

HighTower Advisors reduced its Medtronic (MDT) stake by 8.5% in Q1 2026, selling an estimated $11.7M and leaving 1,322,661 shares worth $115M. The position accounts for 0.12% of the portfolio, ranked #172.

HighTower Advisors first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $139M in Q3 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

HighTower Advisors held 1,322,661 shares of Medtronic worth $115M as of Q1 2026.
HighTower Advisors sold 122,260 Medtronic shares in Q1 2026, an estimated $11.7M.
Medtronic made up 0.12% of HighTower Advisors's portfolio in Q1 2026, its #172 holding.
HighTower Advisors first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
HighTower Advisors's Medtronic position peaked at $139M in Q3 2025.
2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.